'Platelet aggregation' diaporamas de présentation

Hemolytic Anemia: Nonimmune Defects

1.63k views • 84 slides

ARACHIDONIC ACID, PROSTANOID METABOLISM and DRUGS AFFECTING INFLAMMATORY DISEASE

ARACHIDONIC ACID, PROSTANOID METABOLISM and DRUGS AFFECTING INFLAMMATORY DISEASE. Introduction Biosynthesis Inhibition of Biosynthesis Physiology of the Prostanoids NSAIDs Adverse Effects - Correlation with Physiology Corticosteroids as Antiinflammatories Other Anti-inflammatories/DMARDs.

814 views • 63 slides

Disseminated Intravascular Coagulation

Disseminated Intravascular Coagulation. Karim Rafaat, MD. Introduction. DIC (aka consumption coagulopathy, defibrination syndrome) Systemic process producing both thrombosis and hemorrhage Initiated by a number of defined disorders Consists of the following components:

1.23k views • 60 slides

Anticoagulants and Antiplatelets

1.31k views • 40 slides

Chapter 8 Cell Adhesion Molecules (CAM)

Chapter 8 Cell Adhesion Molecules (CAM). Chapter 8 Cell Adhesion Molecules. Contents. Part ? Membrane molecules of immune cell Part ? Definition of leukocyte differentiation antigen and CD Part ? Definition, classification and functions

3.25k views • 39 slides

DUAL ANTIPLATELET THERAPY (DAPT)

DUAL ANTIPLATELET THERAPY (DAPT) . BHAVI SHAH, DNP, APRN, ANP-C UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER DEPARTMENT OF MEDICINE CARDIOLOGY SECTION. WHAT REALLY HAPPENS. Normal endothelium regulates blood flow Tissue Injury Vasoconstriction Release of von Willebrand Factor ( vWF )

1.09k views • 36 slides

Emerging Anticoagulants for VTE Prevention and Treatment: Is change upon us?

Emerging Anticoagulants for VTE Prevention and Treatment: Is change upon us?. Amanda C. Walker, PharmD Clinical Pharmacist University of Utah University Thrombosis Service. Objectives. Describe the pharmacology and mechanism of action for new and emerging anti-thrombotic agents

758 views • 35 slides

548 views • 35 slides

Drugs Used in Coagulation Disorders

Drugs Used in Coagulation Disorders. Assist Professor Dr. Hayder B Sahib. The drugs used in clotting and bleeding disorders fall into 2 major groups: (1) drugs used to decrease clotting or dissolve clots already present in patients at risk for vascular occlusion

807 views • 34 slides

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. MRS. M.M. HAS A 3 YR. HX OF PROGRESSIVE RIGHT HIP PAIN. THE PAIN INCREASES WITH WEIGHT BEARING ACTIVITY. PT. HAS BEEN ON ACETAMINOPHEN WITHOUT RELIEF. PERTINENT LABS INCLUDE CREATININE OF 1.4, X-RAY OSTEOARTHRITIS HIP.

962 views • 32 slides

Dr Than Kyaw 13 February 2012

Cardiovascular System (CVS) L-2: Hematopoiesis , Blood Groups, & Hemostasis. Dr Than Kyaw 13 February 2012. Hematopoiesis Formation of Blood Elements. Erythropoiesis. Hematopoiesis. Leukopoiesis. Mainly formed in the red marrow of many bones.

536 views • 32 slides

441 views • 27 slides

Thromboembolic disease in pregnancy

1.48k views • 24 slides

Stress, Anxiety & Depression: So What Do I Take?

Stress, Anxiety & Depression: So What Do I Take?. Gary E. Foresman, MD July 2013. References. Depression and Risk of Stroke Morbidity and Mortality. An Pan PhD, et al. JAMA. Sept 21, 2011; 306(11): 1241-1249.

534 views • 23 slides

539 views • 22 slides

eosinophils and mast cells

eosinophils and mast cells. eosinophil. Eosinophil : introduction. bone marrow derived granulocytes Myeloid lineage Paul Ehrlich 1879 red, eosinophilic basic granules nucleus divided into two tear-shaped lobes non-dividing - approx 13 hr in circulation usually less than 4% of WBC

726 views • 19 slides

prostaglandins, prostacyclins, thromboxanes, leukotrienes

Eicosanoids. prostaglandins, prostacyclins, thromboxanes, leukotrienes . lipid-derived AUTOCOIDS. arachidonic acid C 20:4 ? 5,8,11,14. The common precursor to these autocoids is arachidonic acid. hormones bind to receptors Ca 2+ released and activates phospholipases. acylhydrolases. 5.

1.06k views • 17 slides

Anti-Coagulants

Anti-Coagulants. Physical Process of Clotting Chemical Process of Clotting Fibrin formation, extrinsic and intrinsic pathways Anti-coagulants Definition Heparin, Low molecular weight heparins, pentasaccharide Structure, properties, biochemical mechanism Coumarins and 1,3-indanediones

290 views • 11 slides

346 views • 10 slides

Management

226 views • 6 slides